Consolidated Balance Sheet (Unaudited) - USD ($)	Jul. 02, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 1,888,000,000	$ 4,477,000,000
Accounts receivable, less allowances of $177 and $150	7,745,000,000	7,977,000,000
Inventories	5,668,000,000	5,051,000,000
Contract assets, net	1,147,000,000	968,000,000
Other current assets	1,652,000,000	1,640,000,000
Total current assets	18,100,000,000	20,113,000,000
Property, plant and equipment, net	8,529,000,000	8,333,000,000
Acquisition-related intangible assets, net	18,578,000,000	20,113,000,000
Other assets	4,306,000,000	4,640,000,000
Goodwill	41,066,000,000	41,924,000,000
Total assets	90,579,000,000	95,123,000,000
Current liabilities:
Short-term obligations and current maturities of long-term obligations	1,010,000,000	2,537,000,000
Accounts payable	2,586,000,000	2,867,000,000
Accrued payroll and employee benefits	1,722,000,000	2,427,000,000
Contract liabilities	2,722,000,000	2,655,000,000
Other accrued expenses	2,957,000,000	2,950,000,000
Total current liabilities	10,997,000,000	13,436,000,000
Deferred income taxes	3,327,000,000	3,837,000,000
Other long-term liabilities	4,534,000,000	4,540,000,000
Long-term obligations	29,250,000,000	32,333,000,000
Redeemable noncontrolling interest	117,000,000	122,000,000
Thermo Fisher Scientific Inc. shareholders’ equity:
Preferred stock, $100 par value, 50,000 shares authorized; none issued	0	0
Common stock, $1 par value, 1,200,000,000 shares authorized; 439,863,357 and 439,154,741 shares issued	440,000,000	439,000,000
Capital in excess of par value	16,467,000,000	16,174,000,000
Retained earnings	39,074,000,000	35,431,000,000
Treasury stock at cost, 48,074,395 and 44,720,112 shares	(10,964,000,000)	(8,922,000,000)
Accumulated other comprehensive items	(2,724,000,000)	(2,329,000,000)
Total Thermo Fisher Scientific Inc. shareholders’ equity	42,293,000,000	40,793,000,000
Noncontrolling interests	61,000,000	62,000,000
Total equity	42,354,000,000	40,855,000,000
Total liabilities, redeemable noncontrolling interest and equity	$ 90,579,000,000	$ 95,123,000,000